| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate |
1979-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1981-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_975cc3e2780646b616560b5fc2b13a39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f9ee8114ee876108393bd30f88c1aa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55fc60dd900c888b914847e579c71a7c |
| publicationDate |
1981-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4271305-A |
| titleOfInvention |
Thiazolinoazetidinones and process therefor |
| abstract |
Novel halogenating compounds, derived from triaryl phosphites and chlorine or bromine are employed to convert 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives. The product 3-halo-3-cephems are antibiotic compounds or intermediates thereto. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5578721-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5604222-A |
| priorityDate |
1979-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |